CVC Explores $2B Sale of Arthea

Private equity firm CVC Capital Partners is exploring a two billion dollar sale for personal care platform Arthea. The company owns popular brands including Dr Teals and Cantu. Discussions regarding the potential transaction remain at an early stage.

Xurve View
Insights:
CVC logo is seen in this illustration taken, September 4, 2026. REUTERS/Dado Ruvic/Illustration

Private equity firm CVC Capital Partners plc is exploring a $2 billion sale of Arthea, the personal care platform behind Dr. Teal's, according to people familiar with the matter. The potential divestment follows CVC's acquisition of the company, formerly known as PDC Brands, for $1.43 billion in 2017. The personal care sector has seen a surge in M&A activity, with several multibillion-dollar deals completed over the past year.

IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.